Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)

Sonali Batta; Austinn C Miller; Susuana Adjei; Laurie A Temiz; Stephen K Tyring

doi:10.1080/08998280.2022.2097572

Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)

Proc (Bayl Univ Med Cent). 2022 Jul 15;35(6):811-812. doi: 10.1080/08998280.2022.2097572. eCollection 2022.

Authors

Sonali Batta¹, Austinn C Miller², Susuana Adjei², Laurie A Temiz^{2

3}, Stephen K Tyring^{2

4}

Affiliations

¹ Texas A&M College of Medicine, Temple, Texas.
² Center for Clinical Studies, Webster, Texas.
³ Meharry Medical School, Nashville, Tennessee.
⁴ Department of Dermatology, University of Texas Health Science Center, Houston, Texas.

Abstract

We present a case of erythema multiforme (EM) associated with a third (booster) dose of COVID-19 vaccination in a patient who had no cutaneous reactions to previous doses. To our knowledge, this is the first documented case of vaccine-associated EM occurring after a third/booster vaccination. Furthermore, our case emphasizes the need to remain vigilant for vaccine-associated EM in any patient recently vaccinated, regardless of whether previous vaccinations were administered without cutaneous reactions.

Keywords: COVID-19; Coronavirus; erythema multiforme; vaccination.

Publication types

Case Reports